1. 1. Jokanovic´, M. Biotransformation of organophosphorus compounds. Toxicology 2001, 166, 139–160. https://doi.org/10.1016/s0300-483x(01)00463-2
2. 2. Damani, L. A., Thioethers, thiols, dithioic acids and disulphides: Phase I reactions In Sulphur-Containing Drugs and related Organic Compounds. Chemistry, Biochemistry and Toxicology, Damani, L. A., Ed. Ellis Horwood Limited: 1989; Vol. 1, pp 131-146. (Doi number is not applicable)
3. 3. Ziegler, D. M., S-Oxygenases, I: Chemistry and Biochemistry In Sulphur-Containing Drugs and related Organic Compounds. Chemistry, Biochemistry and Toxicology. Part A, Ellis Horwood Limited: 1989; Vol. 2, pp 53-66. Doi number is not applicable)
4. 4. Mitchard, R. L. M. a. J. A. B., H2 receptor antagonists. In Sulphur-Containing Drugs and related Organic Compounds. Chemistry, Biochemistry and Toxicology, 1989, pp 54-87. (Doi number is not applicable)
5. 5. Rydberg, P., Ryde, U., Olsen, L., Sulfoxide, Sulfur, and Nitrogen Oxidation and Dealkylation by Cytochrome P450. J Chem Theory Comput 2008, 4 (8), 1369-77. https://doi.org/ 10.1021/ct800101v